The Cystic Fibrosis affects approximately one out of 2500 newborns.
Cystic Fibrosis (CF)
CF is caused by a malfunction of cellular salt processing leading to mucus build-up in the airways and pancreas. This causes chronic airway infection, stunted growth, and serious illness if it remains untreated. Milder variants are also known, which are sometimes not diagnosed until adulthood.
With the use of intensive inhalations, chest physiotherapy, and an appropriate diet involving the supplementation of digestive enzymes and fat-soluble vitamins, unnecessary hospitalisations can be avoided and a normal development is possible.
CF is the most common congenital metabolic disease, which affects one in 2500 newborns.
There are just as many treatment options for CF as there are different symptoms. Respiratory physical therapy and inhalation therapy, the taking of antibiotics, diet, or lung transplantation.
One of the standard treatments for CF is the daily inhalation of mucous-dissolving medications.
Swiss association for CF